Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

TMDX

TransMedics Group, Inc.

Electromedical & Electrotherapeutic Apparatus · SIC 3845CIK 1756262Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$605.0M
Net Income FY2025
$190.0M
EPS (Basic, as reported)
$5.60
Net Margin FY2025
31.4%
ROE FY2025
40.2%
Total Equity
$473.0M
Shares Out
35M
Business description

TransMedics Group, Inc. — Electromedical & Electrotherapeutic Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 15 → 605 +69.6% CAGR
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1526283193242442605
Cost of revenue(7)(10)(9)(9)(28)(88)(179)(243)
Gross profit614172165154262363
Research & development(14)(20)(19)(22)(27)(36)(56)(69)
Selling, general & administrative(12)(24)(24)(38)(70)(120)(169)(185)
Total operating expenses(26)(43)(43)(61)(97)(183)(225)(254)
Operating income(20)(30)(26)(39)(31)(29)37109
Interest expense(3)(4)(4)(4)(4)(11)(14)(14)
Other income (expense), net(3)(4)(2)(5)(5)2(2)(1)
Pre-tax income(24)(34)(29)(44)(36)(27)36108
Income tax expense000—0(2)0(83)
Net income(24)(34)(29)(44)(36)(25)35190
EPS — basic——($1.16)($1.60)($1.23)($0.77)$1.07$5.60
EPS — diluted——($1.16)($1.60)($1.23)($0.77)$1.01$4.87
Shares outstanding — basic (M)——252830333334
Shares outstanding — diluted (M)——252830333541

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.